546
Views
2
CrossRef citations to date
0
Altmetric
ORIGINAL RESEARCH

Retinoic acid receptor alpha: One of plasma biomarkers associated with exacerbation of chronic obstructive pulmonary disease

, , , , , , , , , , , , , , & show all

References

  • CD Mathers, DM Fat, JT Boerma. The Global Burden of Disease: 2004 Update. Geneva: World Health Organization; 2008.
  • DW Brown, JB Croft, PhD, KJ Greenlund, PhD, WH Giles, MD. Deaths from Chronic Obstructive Pulmonary Disease-United States, (2000–2005). Centers for Disease Control and Prevention. Atlanta, USA 2008 / 57(45); 1229–1232.
  • Mathers CD, Loncar D. Projection of global mortality and burden of diseases from 2002 to 2030. PloS Med 2006; 3:e442.
  • Burrows B, Earle RH. Course and prognosis of chronic obstructive lung disease: A prospective study of 200 patients. N Engl J Med 1969; 280: 397–404.
  • B Celli, GL Snider, J Heffner. Definitions, epidemiology, pathophysiology, diagnosis, and staging. Am J Respir Crit Care Med 1995; 152: Suppl: S78–S83.
  • Hurst JR, Vestbo J, Anzueto A, : Susceptibility to exacerbation in chronic obstructive pulmonary disease. N Engl J Med 2010; 363:1128–38.
  • Decramer M, Celli B, Kesten S, Lystig T, Mehra S, Tashkin DP. Effect of tiotropium on outcomes in patients with moderate chronic obstructive pulmonary disease (UPLIFT): a prespecified subgroup analysis of a randomized controlled trial. Lancet 2009; 374:1171–1178.
  • Gudmundsson G, Gislason T, Lindberg E, Hallin R, UlrikCS, Brøndum E, Nieminen MM, Aine T, Bakke P, Janson C. Mortality in COPD patients discharged from hospital: the role of treatment and co-morbidity. Respir Res 2006; 7:109
  • Celli BR, Cote CG, Marin JM, The body-mass index, airflow obstruction, dyspnea, and exercise capacity index in Chronic Obstructive Pulmonary Disease. N Engl J Med 2004; 350:1005–1012.
  • .10. Gan WQ, Man SF, Senthilselvan A, Sin DD. Association between chronic obstructive pulmonary disease and systemic inflammation: a systematic review and a meta-analysis. Thorax 2004; 59:574–580.
  • Pinto-Plata V, Toso J, Lee K, Parks D, Bilello J, Mullerova H, De Souza MM, Vessey R, Celli B. Profiling serum biomarkers in patients with COPD: Associations with clinical parameters. Thorax 2007; 62:595–601.
  • Dahl M, Tybjaerg-Hansen A, Vestbo J, Elevated plasma fibrinogen associated with reduced pulmonary function and increased risk of chronic obstructive pulmonary disease. Am J Respir Crit Care Med 2001; 164:1008–1125.
  • Koutsokera A, Stolz D, Loukides S, Kostikas K. Systemic biomarkers in exacerbations of COPD: The evolving clinical challenge. CHEST 2012; 141(2):396–405.
  • Global Initiative for Chronic Obstructive Lung Disease –GOLD [home page on the Internet]. Bethesda: Global Initiative for Chronic Obstructive Lung Disease [cited 2012 Mar 13]. Global strategy for the diagnosis, management and prevention of COPD - Revised 2011. [Adobe Acrobat document, 90p.]. Available from: http://www.goldcopd.org/uploads/users/files/GOLD_Report_2011_Feb21.pdf
  • Rhim T, Choi YS, Nam BY, Uh ST, Park JS, Kim YH, Paik YK, Park CS. Plasma protein profiles in early asthmatic responses to inhalation allergen challenge. Allergy 2009; 64(1):47–54.
  • Shevchenko A, Wilm M, Vorm O, Mann M, Mass spectrometric sequencing of proteins silver-stained polyacrylamide gels. Anal Chem 1996; 68:850–858.
  • Maden M, Hind M. Retinoic acid in alveolar development, maintenance and regeneration. Philos Trans Roy Soc Lond B: Biol Sci 2004; 359:799.
  • McGowan S, Jackson SK, Jenkins-Moore M, Dai HH, Chambon P, Snyder JM. Mice bearing deletions of retinoic acid receptors demonstrate reduced lung elastin and alveolar numbers. Am J Respir Cell Mol Biol 2000; 23:162–167.
  • Vogel S, Gamble MV, Blaner WS. Biosynthesis, absorption, metabolism and transport of retinoids. In: Retinoids. The Biochemical and Molecular Basis of Vitamin A and Retinoid Action. Nau H, Blaner WS, eds.; Berlin: Springer-Verlag, 1999.
  • Frankenberger M, Hauck RW, Frankenberger B, Haussinger K, Maier KL, Heyder J, Ziegler-Heitbrock HW. All trans-retinoic acid selectively down-regulates matrix metalloproteinase-9 (MMP-9) and up-regulates tissue inhibitor of metalloproteinase-1 (TIMP-1) in human bronchoalveolar lavage cells. Mol Med 2001; 7:263.
  • Mao JT, Tashkin DP, Belloni PN, Baileyhealy I, Baratelli F, Roth MD. All-trans retinoic acid modulates the balance of matrix metalloproteinase-9 and tissue inhibitor of metalloproteinase-1 in patients with emphysema. Chest 2003; 124:1724–1732.
  • Ross AC. Retinoid production and catabolism: role of diet in regulating retinol esterification and retinoic acid oxidation. J Nutr 2003; 133: 291S–196S.
  • Wang XD, Liu C, Bronson RT, Smith DE, Krinsky NI, Russell M. Retinoid signaling and activator protein-1 expression in ferrets given beta-carotene supplements and exposed to tobacco smoke. J Natl Cancer Inst 1999; 91:60–66.
  • Gordon C, Gudi K, Krause A, Sackrowitz R, Harvey B-G, Strulovici-Barel Y, Mezey JG, Crystal RG. Circulating endothelial microparticles as a measure of early lung destruction in cigarette smokers. Am J Respir Crit Care Med 2011; 184:224–232.
  • Demedts IK, Demoor T, Bracke KR, Joos GF, Brusselle GG. Role of apoptosis in the pathogenesis of COPD and pulmonary emphysema. Respir Res 2006; 7:53
  • Barreiro E, Ferrer D, Sanchez F, Minguella J, Marin-Corral J, Martinez-Llorens J, Lloreta J, Gea J. Inflammatory cells and apoptosis in respiratory and limb muscles of patients with COPD. J Appl Physiol 2011 Sep; 111(3):808–817.
  • Lim SC, Ju JY, Chi SY, Ban HJ, Kwon YS, Oh IJ, Kim KS, Kim YI, Kim YC. Apoptosis of T lymphocytes isolated from peripheral blood of patients with acute exacerbation of chronic obstructive pulmonary disease. Yonsei Med J 2011; 52(4):581–587.
  • Hacker S, Lambers C, Pollreisz A, Increased soluble serum markers caspase-cleaved cytokeratin-18, histones, and ST2 indicate apoptotic turnover and chronic immune response in COPD J Clin Lab Anal 2009; 23: 372–379.
  • Tilley AE, O'Connor TP, Hackett NR, Strulovici-Barel Y, Salit J, Biologic phenotyping of the human small airway epithelial response to cigarette smoking. PLoS ONE 2011; 6(7):e22798.
  • Beane J, Shah V, Liu G, Schembri F, Yang X, Palma J, Brody JS. Effects of cigarette smoke on the human airway epithelial cell transcriptome. Proc Natl Acad Sci USA 2004; 101:10143–10148.
  • Pierrou S, Broberg P, O'Donnell RA, Pawlowski K, Virtala R, Expression of genes involved in oxidative stress responses in airway epithelial cells of smokers with chronic obstructive pulmonary disease. Am J Respir Crit Care Med 2007; 175:577–586.
  • Blacque OE, Li C, Inglis PN, Esmail MA, Ou G, Mah AK, Baillie DL, Scholey JM, Leroux MR. The WD Repeat-containing Protein IFTA-1 Is required for retrograde intraflagellar transport. Mol Biol Cell 2006; 17(12):5053–5062.
  • Yaghi A, Zaman A, Cox G, Dolovich MB. Ciliary beating is depressed in nasal cilia from chronic obstructive pulmonary disease subjects. Respir Med 2012; 106(8):1139–1147.
  • Murai J, Huang SY, Das BB, Dexheimer TS, Takeda S, Pommier Y. Tyrosyl-DNA phosphodiesterase 1 (TDP1) repairs DNA damage induced by topoisomerases I and II and base alkylation in vertebrate cells. J Biol Chem 2012; 287(16):12848–12857. Epub 2012 Feb 27.
  • Jameson J, Witherden D, Havran WL. T-cell effector mechanisms: gammadelta and CD1d-restricted subsets. Curr Opin Immunol 2003; 15:349–353.
  • Pons J, Sauleda J, Ferrer JM, Barceló B, Fuster A, Regueiro V, Julià MR, Agustí AG. Blunted gamma delta T-lymphocyte response in chronic obstructive pulmonary disease. Eur Respir J 2005; 25(3):441–446.
  • Cox DW. Alpha-1 antitrypsin deficiency. In: Scriver CR, Beaudet AL, Sly WS, , eds. The Metabolic and Molecular Bases of Inherited Disease. 8th Ed.; Vol. 4. New York: McGraw-Hill, 2001: 5559–5584.
  • Scott FL, Hirst CE, Sun J, Bird CH, Bottomley SP, Bird PI. The intracellular serpin proteinase Inhibitor 6 Is expressed in monocytes and granulocytes and is a potent inhibitor of the azurophilic granule protease, Cathepsin G. Blood 1999; 93:2089–2097.
  • Zhou Q, Salvesen GS. Activation of pro-caspase-7 by serine proteases includes a non-canonical specificity. Biochem J 1997; 324:361.
  • Scott FL, Coughlin PB, Bird C, Cerruti L, Hayman JA, Bird P. Proteinase inhibitor 6 cannot be secreted, which suggests it is a new type of cellular serpin. J Biol Chem 1996; 271:1605.
  • Farrell DH. Pathophysiologic roles of the fibrinogen gamma chain. Curr Opin Hematol 2004; 11:151–155.
  • Mosesson MW. Fibrinogen gamma chain functions. J Thromb Haemost 2003; 1:231–238.
  • Schols A, Mostert R, Soeters P, Greve LH, Wouters EF. Inventory of nutritional status in patients with COPD. Chest 1989 Aug; 96(2):247–249.
  • MacNee W. Pathogenesis of Chronic Obstructive Pulmonary Disease. Proc Am Thorac Soc 2005; 2:258–266.
  • Perera WR, Donaldson GC, Wedzicha JA, Inflammatory changes, recovery and recurrence at COPD exacerbation. Eur Respir J 2007; 29:527–534.
  • Hurst JR, Donaldson GC, Wedzicha A, Use of plasma biomarkers at exacerbation of chronic obstructive pulmonary disease. Am J Respir Crit Care Med 2006; 174:867–874.
  • Seligman R, Papassotiriou J, Morgenthaler NG, Meisner M, Teixeira PJZ. Copeptin, a novel prognostic biomarker in ventilator-associated pneumonia. CHEST 2007; 131:1058–1067.
  • Rodriguez-Roisin R. Toward a consensus definition for COPD exacerbations. Chest 2000; 117:398S–401S.
  • Terracciano R, Preiano M, Peptidome profiling of induced sputum by mesoporous silica beads and MALDI-TOF MS for non-invasive biomarker discovery of chronic inflammatory lung diseases. Proteomics 2011, 11, 3402–3414.
  • Lee EJ, In KH, Proteomic analysis in lung tissue of smokers and COPD patients. CHEST 2009; 135:344–352.
  • Verrills NM, Irwin JA, He XY, Identification of novel diagnostic biomarkers for asthma and Chronic Obstructive Pulmonary Disease. Am J Respir Crit Care Med 2011; 183:1633–1643.
  • Pastor MD, Nogal A, Identification of oxidative stress related proteins as biomarkers for lung cancer and Chronic Obstructive Pulmonary Disease in bronchoalveolar lavage. Int J Mol Sci 2013; 14:3440–3455.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.